Breast Cancer

Top Story

Atezolizumab plus chemotherapy approved for triple-negative breast cancer, small cell lung cancer

Atezolizumab plus chemotherapy approved for triple-negative breast cancer, small cell lung cancer
HemOnc Today, April 25, 2019

Use of genetic testing to guide breast cancer treatment could reduce costs

April 24, 2019
Personalizing treatment for patients with breast cancer based on tumor genetic profiles could reduce costs during the first year of care, according to results of a…
In the Journals

Digital breast tomosynthesis improves specificity of breast cancer detection

April 24, 2019
Screening with 3-D digital breast tomosynthesis appeared associated with increases in both specificity and proportion of breast cancers detected with better prognosis…

Multigene testing ‘not leading to more worry’ for patients with breast cancer

April 23, 2019
Multigene panel genetic testing did not increase worry among patients with breast cancer compared with BRCA1/BRCA2 testing alone, according to study results published…
More Headlines »
CME

Updates in Hematologic Malignancies: What You Might Have Missed in San Diego

This activity is supported by an educational grant from Pharmacyclics LLC.

Therapeutic options continue to expand for patients with hematologic malignancies. The clinical evaluation of novel…
More »
Video
Meeting News

VIDEO: Bayer executive highlights ASCO data in breast cancer, urothelial carcinoma, glioblastoma

June 21, 2018
More »
Resource Centers

CME CNE

Improving Colorectal Cancer Screening and Prevention: Advances in Polyp Detection and Resection

This activity is supported by an educational grant from Aries Pharmaceuticals, Inc.

Colorectal cancer (CRC) is the third most common type of cancer worldwide and the second deadliest form of cancer in…
More »